BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28874966)

  • 1. Characterization of acetate transport in colorectal cancer cells and potential therapeutic implications.
    Ferro S; Azevedo-Silva J; Casal M; Côrte-Real M; Baltazar F; Preto A
    Oncotarget; 2016 Oct; 7(43):70639-70653. PubMed ID: 28874966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MCT1, MCT4 and CD147 expression and 3-bromopyruvate toxicity in colorectal cancer cells are modulated by the extracellular conditions.
    Pereira-Vieira J; Azevedo-Silva J; Preto A; Casal M; Queirós O
    Biol Chem; 2019 May; 400(6):787-799. PubMed ID: 30699066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocarboxylate transport inhibition potentiates the cytotoxic effect of 5-fluorouracil in colorectal cancer cells.
    Amorim R; Pinheiro C; Miranda-Gonçalves V; Pereira H; Moyer MP; Preto A; Baltazar F
    Cancer Lett; 2015 Aug; 365(1):68-78. PubMed ID: 26021766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of glycolytic metabolism-related protein expression in colorectal cancer, lymph node and hepatic metastasis.
    Martins SF; Amorim R; Viana-Pereira M; Pinheiro C; Costa RF; Silva P; Couto C; Alves S; Fernandes S; Vilaça S; Falcão J; Marques H; Pardal F; Rodrigues M; Preto A; Reis RM; Longatto-Filho A; Baltazar F
    BMC Cancer; 2016 Jul; 16():535. PubMed ID: 27460659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas.
    Pinheiro C; Longatto-Filho A; Scapulatempo C; Ferreira L; Martins S; Pellerin L; Rodrigues M; Alves VA; Schmitt F; Baltazar F
    Virchows Arch; 2008 Feb; 452(2):139-46. PubMed ID: 18188595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4.
    Hong CS; Graham NA; Gu W; Espindola Camacho C; Mah V; Maresh EL; Alavi M; Bagryanova L; Krotee PAL; Gardner BK; Behbahan IS; Horvath S; Chia D; Mellinghoff IK; Hurvitz SA; Dubinett SM; Critchlow SE; Kurdistani SK; Goodglick L; Braas D; Graeber TG; Christofk HR
    Cell Rep; 2016 Feb; 14(7):1590-1601. PubMed ID: 26876179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cytotoxicity of 3-bromopyruvate in breast cancer cells depends on extracellular pH.
    Azevedo-Silva J; Queirós O; Ribeiro A; Baltazar F; Young KH; Pedersen PL; Preto A; Casal M
    Biochem J; 2015 Apr; 467(2):247-58. PubMed ID: 25641640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monocarboxylate Transporters MCT1 and MCT4 Regulate Migration and Invasion of Pancreatic Ductal Adenocarcinoma Cells.
    Kong SC; Nøhr-Nielsen A; Zeeberg K; Reshkin SJ; Hoffmann EK; Novak I; Pedersen SF
    Pancreas; 2016 Aug; 45(7):1036-47. PubMed ID: 26765963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Butyrate activates the monocarboxylate transporter MCT4 expression in breast cancer cells and enhances the antitumor activity of 3-bromopyruvate.
    Queirós O; Preto A; Pacheco A; Pinheiro C; Azevedo-Silva J; Moreira R; Pedro M; Ko YH; Pedersen PL; Baltazar F; Casal M
    J Bioenerg Biomembr; 2012 Feb; 44(1):141-53. PubMed ID: 22350013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of lactate/H⁺ symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses.
    Kim Y; Choi JW; Lee JH; Kim YS
    Hum Pathol; 2015 Jan; 46(1):104-12. PubMed ID: 25456395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms of monocarboxylate transporter genes are associated with clinical outcomes in patients with colorectal cancer.
    Fei F; Guo X; Chen Y; Liu X; Tu J; Xing J; Chen Z; Ji J; He X
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):1095-102. PubMed ID: 25492048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose deprivation increases monocarboxylate transporter 1 (MCT1) expression and MCT1-dependent tumor cell migration.
    De Saedeleer CJ; Porporato PE; Copetti T; Pérez-Escuredo J; Payen VL; Brisson L; Feron O; Sonveaux P
    Oncogene; 2014 Jul; 33(31):4060-8. PubMed ID: 24166504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monocarboxylate transporter 1 (MCT1) mediates transport of short-chain fatty acids in bovine caecum.
    Kirat D; Kato S
    Exp Physiol; 2006 Sep; 91(5):835-44. PubMed ID: 16857719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of lactate transporters (MCT1 and MCT4) in heart and muscle.
    Bonen A
    Eur J Appl Physiol; 2001 Nov; 86(1):6-11. PubMed ID: 11820324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic disruption of lactate/H+ symporters (MCTs) and their subunit CD147/BASIGIN sensitizes glycolytic tumor cells to phenformin.
    Marchiq I; Le Floch R; Roux D; Simon MP; Pouyssegur J
    Cancer Res; 2015 Jan; 75(1):171-80. PubMed ID: 25403912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors.
    Birsoy K; Wang T; Possemato R; Yilmaz OH; Koch CE; Chen WW; Hutchins AW; Gultekin Y; Peterson TR; Carette JE; Brummelkamp TR; Clish CB; Sabatini DM
    Nat Genet; 2013 Jan; 45(1):104-8. PubMed ID: 23202129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis.
    Lee JY; Lee I; Chang WJ; Ahn SM; Lim SH; Kim HS; Yoo KH; Jung KS; Song HN; Cho JH; Kim SY; Kim KM; Lee S; Kim ST; Park SH; Lee J; Park JO; Park YS; Lim HY; Kang WK
    Oncotarget; 2016 Jul; 7(28):43492-43503. PubMed ID: 27224918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy-induced DNA methylation inactivates MCT1 and renders tumor cells vulnerable to MCT4 inhibition.
    Vander Linden C; Corbet C; Bastien E; Martherus R; Guilbaud C; Petit L; Wauthier L; Loriot A; De Smet C; Feron O
    Cell Rep; 2021 Jun; 35(9):109202. PubMed ID: 34077729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis.
    Bovenzi CD; Hamilton J; Tassone P; Johnson J; Cognetti DM; Luginbuhl A; Keane WM; Zhan T; Tuluc M; Bar-Ad V; Martinez-Outschoorn U; Curry JM
    Biomed Res Int; 2015; 2015():242437. PubMed ID: 26779534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of 3-bromopyruvate on human colorectal cancer cells is dependent on glucose concentration but not hexokinase II expression.
    Ho N; Morrison J; Silva A; Coomber BL
    Biosci Rep; 2016 Jan; 36(1):e00299. PubMed ID: 26740252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.